Cymbio Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 2.50 Cr
as on 06-07-2024
- Company Age 26 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.35 Cr
as on 06-07-2024
- Satisfied Charges ₹ 4.10 Cr
as on 06-07-2024
- Revenue -0.05%
(FY 2023)
- Profit -78.36%
(FY 2023)
- Ebitda -57.74%
(FY 2023)
- Net Worth 4.43%
(FY 2023)
- Total Assets 25.02%
(FY 2023)
About Cymbio Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹7.35 Cr. The company has closed loans amounting to ₹4.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Fiona Karle, Mahendra Karle, Sudarshan Karle, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110KA1998PTC024210
- Company No.
024210
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cymbio Pharma Private Limited offer?
Cymbio Pharma Private Limited offers a wide range of products and services, including Cooking Spices and Masala, Vegetable Powders, Brain & Nervous System Drugs, Antimigraine Drug, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Ayurvedic & Herbal Extracts, Plant Extracts, Herbal Extracts, Black Tea Extract.
Who are the key members and board of directors at Cymbio Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Fiona Karle  | Director | 24-May-2004 | Current |
| Mahendra Karle | Director | 24-May-2003 | Current |
| Sudarshan Karle | Director | 24-May-2003 | Current |
Kyung Cho  | Director | 24-May-2004 | Current |
Financial Performance and Corporate Structure Insights of Cymbio Pharma.
Cymbio Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.05% decrease. The company also saw a substantial fall in profitability, with a 78.36% decrease in profit. The company's net worth moved up by a moderate rise of 4.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cymbio Pharma?
In 2023, Cymbio Pharma had a promoter holding of 95.88% and a public holding of 4.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Karle Homes Private LimitedActive 13 years 22 daysMahendra Karle and Sudarshan Karle are mutual person
Karle Health Sciences Private LimitedActive 18 years 5 monthsMahendra Karle and Sudarshan Karle are mutual person
- Karle Tech Park Private LimitedActive 16 years 11 months
Mahendra Karle and Sudarshan Karle are mutual person
- Karle International Private LimitedActive 16 years 3 months
Mahendra Karle and Sudarshan Karle are mutual person
- Karle Lifestyle Ventures Private LimitedActive 16 years 11 months
Mahendra Karle and Sudarshan Karle are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2021 | ₹3.50 M | Open |
Others Creation Date: 26 Jun 2014 | ₹7.00 Cr | Open |
State Bank Of India Creation Date: 22 Apr 1999 | ₹2.05 Cr | Satisfied |
How Many Employees Work at Cymbio Pharma?
Cymbio Pharma has a workforce of 34 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cymbio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cymbio Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
